FAR1 - fatty acyl-CoA reductase 1 Gene
Also Known as CSPSD; PFCRD; MLSTD2; SDR10E1
Species: Homo sapiens
About FAR1
This gene has 7 transcripts (splice variants), 246 orthologues, 1 paralogue and is associated with 5 phenotypes. Ubiquitous expression in esophagus (RPKM 26.7), stomach (RPKM 25.1) and 24 other tissues.
Summary
The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
FAR1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_032228.6 | NP_115604.1 | fatty acyl-CoA reductase 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables alcohol-forming very long-chain fatty acyl-CoA reductase activity |
IDA
IDA: Inferred from direct assay
|
15220348 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
32814053 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in ether lipid biosynthetic process |
IDA
IDA: Inferred from direct assay
|
24108123 | GOA |
| involved in ether lipid biosynthetic process |
IMP
IMP: Inferred from mutant phenotype
|
20071337 | GOA |
| involved in glycerophospholipid biosynthetic process |
IDA
IDA: Inferred from direct assay
|
20071337 | GOA |
| involved in long-chain fatty-acyl-CoA metabolic process |
IDA
IDA: Inferred from direct assay
|
15220348 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in peroxisomal membrane |
IDA
IDA: Inferred from direct assay
|
24108123 | GOA |
| located in peroxisome |
IDA
IDA: Inferred from direct assay
|
20071337 | GOA |
FAR1 Protein Structure
NAD_binding_4: Male sterility protein (15 - 284)
Sterile: Male sterility protein (356 - 448)
- 0
- 100
- 200
- 300
- 400
- 515 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fatty acyl-CoA reductase 1 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Peroxisomal Fatty Acyl-Coa Reductase 1 Disorder |
|
|
| Cataracts, Spastic Paraparesis, And Speech Delay |
|
|
| Spastic Paraplegia 9a, Autosomal Dominant |
|
|
| Rhizomelic Chondrodysplasia Punctata, Type 5 |
|
|
| Epilepsy |
|
|
| Spasticity |
|
|
| Spastic Paraplegia 83, Autosomal Recessive |
|
|
| Spastic Paraplegia 81, Autosomal Recessive |
|
|
| Rhizomelic Chondrodysplasia Punctata, Type 2 |
|
|
| Chondrodysplasia Punctata Syndrome |
|
|
| Spastic Paraparesis |
|
|
| Rhizomelic Chondrodysplasia Punctata |
|
|
| Microcephaly |
|
|
| Peroxisomal Biogenesis Disorder |
|
|
| Peroxisomal Disease |
|
|
| Zellweger Syndrome |
|
|
| Peroxisome Biogenesis Disorder 1b |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | FAR1 | MGD | MGI:1914670 |
| Bos taurus | FAR1 | VGNC | VGNC:28863 |
| Rattus norvegicus | FAR1 | RGD | RGD:1306647 |
| Macaca mulatta | FAR1 | VGNC | VGNC:103817 |
| Felis catus | FAR1 | VGNC | VGNC:62147 |
| Canis familiaris | FAR1 | VGNC | VGNC:40728 |
| Others | FAR1 | NCBI |